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Background: Little is known about factors associated with carbapenem-resistant Klebsiella
pneumoniae infections in pediatric patients, who are initally colonized with carbapenem-
resistant Klebsiella pneumoniae.
Materials and methods: A retrospective case–control study was conducted involving pediatric
and neonatal intensive care units throughout a ﬁve-year period (January 2010–December
2014).  Clinical and microbiological data were extracted from Hospital Infection Con-
trol Committee reports and patients’ medical records. Risk factors were assessed in
carbapenem-resistant Klebsiella pneumoniae colonized patients who developed subsequent
systemic infection (cases) and compared to carbapenem-resistant Klebsiella pneumoniae col-
onized patients who did not develop infection (controls).
Results: Throughout the study period, 2.6% of patients admitted to neonatal inten-
sive care units and 3.6% of patients admitted to pediatric intensive care units had
become colonized with carbapenem-resistant Klebsiella pneumoniae.  After a mean of
10.6  ± 1.9 days (median: 7 days, range: 2–38 days) following detection of colonization,
39.0% of the carbapenem-resistant Klebsiella pneumoniae colonized patients in pediatric
intensive care units and 18.1% of carbapenem-resistant Klebsiella pneumoniae colonizedpatients in neonatal intensive care units developed systemic carbapenem-resistant
Klebsiella pneumoniae infection. Types of systemic carbapenem-resistant Klebsiella pneu-
moniae infections included bacteremia (n = 15, 62.5%), ventilator-associated pneumonia
(n  = 4, 16.6%), ventriculitis (n = 2, 8.3%), intraabdominal infections (n = 2, 8.3%), and uri-
nary tract infection (n = 1, 4.1%). A logistic regression model including parameters found
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signiﬁcant in univariate analysis of carbapenem resistant Klebsiella pneumoniae coloniza-
tion and carbapenem resistant Klebsiella pneumoniae infection groups revealed underlying
metabolic disease (OR: 10.1; 95% CI: 2.7–37.2), previous carbapenem use (OR: 10.1; 95% CI:
2.2–40.1), neutropenia (OR: 13.8; 95% CI: 3.1–61.0) and previous surgical procedure (OR: 7.4;
95%  CI: 1.9–28.5) as independent risk factors for carbapenem-resistant Klebsiella pneumo-
niae infection in patients colonized with carbapenem-resistant Klebsiella pneumoniae. Out
of  24 patients with carbapenem resistant Klebsiella pneumoniae infection, 4 (16.6%) died of
carbapenem-resistant Klebsiella pneumoniae sepsis.
Conclusion: Asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in
intensive care units of pediatric departments should alert health care providers about forth-
coming carbapenem-resistant Klebsiella pneumoniae infection. Those carbapenem-resistant
Klebsiella pneumoniae colonized patients at risk of developing infection due to carbapenem-
resistant Klebsiella pneumoniae may be targeted for interventions to reduce subsequent
infection occurence and also for timely initiation of empirical carbapenem-resistant Kleb-
siella pneumoniae active treatment, when necessary.
© 2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
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lebsiella pneumonia is a Gram negative rod belonging to
nterobacteriaceae family. Carbapenem resistance in Kleb-
iella pneumonia is mainly associated with K. pneumoniae
arbapenemase.1–3 It is a carbapenem hydrolizing beta-
actamase encoded by transmissible plasmids, which facilitate
pread of the enzyme among bacterial species.4 During the
ast decade, infections due to carbapenem resistant Klebsiella
neumoniae (CRKP) has been reported throughout the world,
preading from the United States in 2001.2 Outbreaks of CRKP
as been reported in several countries.5,6 Rapid and global dis-
emination of CRKP is of great concern in health care facilities.
t can cause diverse infections including primary bacteremia,
rinary tract infections, pneumonia, intra-abdominal infec-
ions, and wound infections. Crude mortality rate of CRKP
nfections ranges from 30% to 44%.7–9 It increases strikingly
o 71.9%, when in the case of bacteremia.10 CRKP strains
ave higher mortality rate compared to strains susceptible to
arbapenem.7,10
Prompt initiation of appropriate antibiotic therapy for CRKP
nfections is crucial for patient survival.8,11,12 However, appro-
riate antibiotics like colistin are not administered routinely
o these patients until the cultures yield CRKP isolate. Know-
ng that a patient is colonized by CRKP may be beneﬁcial in
eciding to start empirical CRKP active treatment in suspicion
f a Gram negative infection.
Risk factors for acquisition of CRKP colonization have been
ainly assessed in studies involving adult patients and were
dentiﬁed as antibiotic exposure, especially carabapenem,
ntensive care unit stay, prolonged hospitalization, poor func-
ional status, invasive devices.7,8,13–15 CRKP colonization of
he host is a major predisposing factor for developing sub-
equent CRKP infection.7,16 The studies which evaluate the
requency and risk factors of CRKP infection occurrence in
atients rectally colonized with CRKP are limited in the pedi-
tric population. Therefore, the present study was planned to
etermine the frequency distribution and description of CRKPlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
infections in rectally colonized patients, who were admitted
in pediatric and neonatal intensive care units over ﬁve years,
as well as to identify associated risk factors for developing
subsequent CRKP infection.
Materials  and  methods
Hospital  setting,  data  collection  and  study  design
This report is a retrospective case–control study conducted
in a tertiary university teaching hospital in Istanbul, Turkey.
Since January 2010, infection control nurses assigned from the
Hospital Infection Control Committee (HICC) have performed
active surveillance of CRKP and vancomycin-resistant entero-
cocci (VRE) rectal colonization in selective high risk wards,
including pediatric and neonatal intensive care units (PICU
and NICU, respectively). Rectal swabs of patients admitted to
PICU or NICU were routinely screened once a week for the
presence of CRKP and VRE. An infection control nurse prospec-
tively tracked all health care associated infections occurring
at the PICU and NICU, together with the results of rectal
surveillance and reported these data monthly to the HICC.
This database was reviewed to identify pediatric patients who
were rectally colonized with CRKP and those who  developed
subsequent CRKP infection from January 2010 to December
2014.
Medical, microbiological and laboratory data were
extracted from HICC reports and the patients’ own med-
ical records. The data collected from patients with CRKP
colonization included demographics, hospital unit at the time
of CRKP detection, underlying diseases, invasive procedures
within previous four weeks, duration and types of antibiotics
use, absolute neutrophil and lymphocyte count at the time of
colonization, and type of CRKP infection. In order to identify
risk factors for CRKP infection among colonized patients, a
case–control study was performed comparing the character-
istics of CRKP colonized patients who developed subsequent
CRKP infection (cases) with CRKP colonized patients who  did
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not developed CRKP infection (controls). Variables related to
the outcome of the infected patients like treatment of CRKP
infection, treatment outcome, length of hospital stay, and
crude in hospital mortality rate were also recorded.
The study protocol was approved by the Institutional
Review Board.
Deﬁnitions
CRKP colonization (CRKP-C) was deﬁned as positive rectal
swab in a patient with no clinical specimens yielding CRKP.
CRKP infection (CRKP-I) was deﬁned as a positive clinical spec-
imen together with signs and symptoms of infection in a
patient previously colonized with CRKP.
Patients with known CRKP colonization prior to admission
or found to be positive in the ﬁrst 72 h of admission were
deﬁned as imported cases. On the other hand, the term cross-
transmission was used for the patients who had negative
rectal swabs in ﬁrst 72 h of admission and who acquired CRKP
colonization subsequently during the current hospitalization.
Undetermined cases were those who could not be sampled in
the ﬁrst 72 h of admission.
HICC determined whether CRKP represented a case of
infection or colonization based on the deﬁnitions of the Cen-
ters for Disease Control and Prevention.17
Microbiological  procedure
Surveillance cultures were collected on sterile stuart trans-
port medium (Pipe star Kft, Budapest, Hungary). After
transportation to the microbiology laboratory, rectal swabs
were inoculated on chromogenic agar supplemented with
1 mg/L meropenem (HiCrome, Himedia, India). After 18–24 h
inoculation at 37 ◦C, dark-blue colonies were identiﬁed at
species level by conventional biochemical methods. Antibi-
otic susuceptibility testing was perfomed by utilizing agar
disk diffusion method (Becton, Dickenson & Company, USA) in
accordance with the Clinical and Laboratory Standards Insti-
tute breakpoints.18 Carbapenem resistance was conﬁrmed
by detection of MIC  values for carbapenems (imipenem,
meropenem, ertapenem) via E-test method (bioMérieux,
France).
Statistics
All statistical analysis was performed with the statistical
package for social science (SPSS) for Windows version 21.0.
Normality was assessed by Shapiro–Wilk test and histogram
graphics. Data are presented as median, minimum, max-
imum, frequency, and percentage. Categorical variables
between groups were compared with the 2 test or Fisher
exact test when the expected cell size was below 5. Normally
distributed continuous variables were compared by Student’s
t test. Mann–Whitney U test was used for continuous vari-
ables, which were not normally distributed. All p-values
were based on two tailed statistical analyses and p-values
less than 0.05 were considered statistically signiﬁcant. Risk
factors for CRKP infection identiﬁed in the univariate analysis
(p ≤ 0.1) were included in the multivariate analysis. Logistic
regression analysis was performed to determine risk factors 1 6;2  0(2):134–140
independently associated with subsequent development of
CRKP infection.
Results
Between January 2010 and December 2014, 2805 patients were
admitted to the intensive care units of our institution (PICU:
1134 patients, NICU: 1671 patients). Throughout the study
period, a total of 85 patients (3.03%) were rectally colonized
with CRKP. Out of those 85 patients carrying CRKP, 44 patients
were admitted at the NICU (2.6% of all patients admitted to
NICU) and 41 patients were admitted at the PICU (3.6% of
all patients admitted to PICU). No signiﬁcant difference was
found between PICU and NICU regarding CRKP colonization
rate (p > 0.05).
Patients’ ages ranged from 1 to 205 months (median:
3 months; mean: 30.7 ± 5.7 months) and 54.1% were male.
On the basis of criteria described in Section “Materials
and methods”, the majority of patients acquired CRKP by
cross-transmission (n = 75, 88.2%), and 9 patients (10.5%) had
imported CRKP. There was only one undetermined case.
Occurrence  of  CRKP  infection
For all patients, frequency of subsequent CRKP infection
among CRKP carriers was 28.2% (24 out of 85). In the NICU,
8 patients out of 44 (18.1%) developed subsequent CRKP infec-
tion, compared 16 patients out of 41 (39%) in the PICU (p = 0.03).
On average, patients developed CRKP infection 35.50 ± 28.78
days (median: 33 days, range: 6–143 days) after admission and
10.6 ± 1.9 days (median: 7 days, range: 2–38 days) after detec-
tion of CRKP colonization. The yearly distribution of CRKP-C
and CRKP-I cases among all admitted patients to PICU and
NICU in that particular year is presented in Figs. 1 and 2,
respectively.
Types of CRKP infection included primary bacteremia in
15 patients (62.5%), ventilator-associated pneumonia in 4
patients (16.6%), ventriculitis in 2 patients (8.3%), intraabdomi-
nal infections in 2 patients (8.3%), and urinary tract infection in
1 patient (4.1%). Two of the primary bacteremia were catheterFig. 1 – The percantage of CRKP-C and CRKP-I cases among
all admitted patients to the pediatric intensive care unit
from 2010 to 2014.
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Fig. 2 – The percantage of CRKP-C and CRKP-I cases among
all admitted patients to the neonatal intensive care unit
from 2010 to 2014.
Table 1 – Clinical characteristics of patients with CRKP-C and CR
CRKP-C 
n = 61 
n (%) 
Co-morbidities 48 (78.7) 
Respiratory diseasea 34 (55.7) 
Malignancy 2 (3.3) 
Neurological diseaseb 15 (24.6) 
Metabolic disease 4 (6.6) 
Immunosuppressionc 28 (45.9) 
Neutropenia 9 (14.8) 
Lymphopenia 5 (8.2) 
Invasive procedures
CVC 48 (78.7) 
PEG 5 (8.2) 
Intubation/MV 48 (78.7) 
Urinary catheterization 20 (32.8) 
Tracheostomy 7 (11.5) 
Surgery 21 (34.4) 
Renal replacement therapy 6 (9.8) 
Thoracic tube drainage 9 (14.8) 
Surgical drainage tube 16 (26.2) 
TPN 31 (50.8) 
Antibiotic Tx before CRKP isolation
Third generation cephalosporin 29 (47.5) 
-Lactam/lactamase combinations 27 (44.2) 
Carbapenems 32 (52.4) 
Glycopeptides 45 (73.8) 
Aminoglycosides 34 (55.7) 
Colistin 4 (6.5) 
Quinolones 12 (19.6) 
CRKP, carbapenem-resistant Klebsiella pneumoniae;  CRKP-C, CRKP colonized
CRKP colonized patients who developed subsequent CRKP infection; CVC,
mechanical ventilation; TPN, total parenteral nutrition; Tx, treatment.
a Including asthma, cystic ﬁbrosis, brochopulmonar dysplasia.
b Including epilepsy, cerebral palsy, neurological sequelae of previous encep
methylmalonic acidemia, lysinuric protein intolerance.
c including chronic granulomatous disease, common variable immune de
monoclonal antibody, and other immunosuppressive agents.6;2 0(2):134–140 137
Risk  factors  for  subsequent  CRKP  infection
Patients with CRKP-I were older in age than those with CRKP-C
(53 ± 14.7 and 23.5 ± 5.8 months, p = 0.039). Length of hospital
stay before detection of CRKP colonization was not different
in CRKP-C and CRKP-I groups (30.6 ± 4.4 and 24.5 ± 5.2 days,
respectively; p = 0.79).
Table 1 summarizes univariate analyses of possible risk
factors associated with subsequent CRKP infection among
patients colonized with CRKP. Presence of underlying chronic
disease was similar in CRKP-C and CRKP-I groups. However,
when individual comorbid diseases were evaluated, CRKP
infected patients had suffered more  frequently from metabolic
and neurological diseases (p = < 0.001 and 0.05, respectively).
When neutrophil counts were compared at the time of CRKP
colonization detection, CRKP colonized patients who  devel-
oped subsequent CRKP infection were more  likely to have
neutropenia than those patients who did not developed subse-
quent CRKP infection (p = 0.02). Individual invasive procedures
KP-I.
CRKP-I p-Value
n = 24
n (%)
22 (91.7) 0.15
11 (45.8) 0.41
2 (8.3) 0.32
11 (45.8) 0.05
10 (41.7) <0.001
16 (66.7) 0.08
11 (45.8) 0.002
5 (20.8) 0.10
24 (100) 0.14
4 (16.7) 0.25
24 (100) 0.14
16 (66.7) 0.04
12 (50) <0.001
18 (75) <0.001
2 (8.3) 0.81
3 (12.5) 0.78
5 (20.8) 0.60
9 (37.5) 0.26
11 (45.8) 0.88
16 (66.7) 0.57
19 (79.1) 0.02
18 (75) 0.90
18 (75) 0.10
0 0.19
7 (29.1) 0.34
 patients who did not developed subsequent CRKP infection; CRKP-I,
 central venous catheter, PEG, percutaneous gastroenterostomy; MV,
halitis. Including mitochondrial diseases, maple syrup urine disease,
ﬁciency, and secondary immune deﬁciency states like use of steroid,
138  b r a z j i n f e c t d i s . 2 0
Table 2 – Multivariate analysis of risk factors for CRKP
infection in patients colonized with CRKP.
Variables p-Value OR (95% CI)
Underlying metabolic disease 0.03 10.1 (2.7–37.2)
Surgery 0.02 7.4 (1.9–28.5)
Previous carbapenem use 0.01 10.1 (2.2–40.1)
Neutropenia 0.02 13.8 (3.1–61.0)CRKP, carbapenem resistant Klebsiella pneumonia.
during their ICU stay differred between the groups. Patients
with CRKP-I had more  urinary catheterization, tracheostomy,
and previous surgical procedure than patients with CRKP-
C (p = 0.04, p < 0.001, p < 0.001, respectively). Total duration of
antibiotic use in patients of CRKP-C and CRKP-I groups were
similar (16.1 ± 1.2 and 10.2 ± 2.0 days, respectively; p = 0.21).
Among different antibiotic groups, carbapenems were more
frequently used in patients with CRKP-I than patients with
CRKP-C (p = 0.02).
A logistic regression analysis including parameters with
a p-value of ≤0.1 in univariate analysis revealed underlying
metabolic disease, previous carbapenem use, neutropenia,
and previous surgical procedure as independent risk factors
for subsequent CRKP infection in patients colonized with CRKP
(Table 2).
Outcome  of  CRKP  infected  patients
Total length of hospital stay was longer in patients with CRKP-I
than those with CRKP-C (70.3 ± 8.4 and 48.6 ± 5.5 days, respec-
tively; p = 0.01). Crude in hospital mortality rate was higher in
CRKP-I group in the limit of statistical signiﬁcance (n = 4 (6.5%)
in CRKP-C vs n = 7 (29.1%) in CRKP-I, p = 0.05). Out of 24 patients
with CRKP-I, 4 (16.6%) died of CRKP sepsis.
Discussion
In daily practice, we are experiencing increasingly rates of
CRKP infection. Treatment of these infections is more  chal-
lenging for pediatricians due to limited appropriate antibiotic
use groups in pediatrics. This real life problem in addition to
the scarcity of pediatric studies on this issue prompted us
to investigate the risk of subsequent CRKP infection of our
CRKP colonized patients admitted to pediatric and neonatal
intensive care units.
Overall, the rate of subsequent a nosocomial CRKP
infection in colonized patients was 28.2%, and PICU had sig-
niﬁcantly higher infection rate than NICU (39% and 18.1%,
respectively). This discrepancy can be explained by the higher
frequency of more  complicated patients with severe underly-
ing diseases at the PICU compared to NICU, which mainly cares
for premature neonates in their way to thrive. To date, there
is no published study that has investigated the prevalance of
neonatal colonization and subsequent infection with CRKP. In
a pediatric study from Turkey, evaluating all pediatric units
for a period of 7 months, a much higher colonization rate
(29.5%), but a lower infection rate (3.4%) in colonized patients
was found.19 In that Low infection rate in that study reﬂects 1 6;2  0(2):134–140
the fact that it did not include only high risk patients, in con-
trary to our studied sample. Adult studies have reported a wide
range of CRKP infection rates among colonizers (8.8–42%).20,21
These differences observed in colonization and subsequent
infection rates among studies may be linked to inclusion
of different patient populations, variations in infrastructural
properties, and implementation of infection control programs.
High colonization rates may indicate poor infection control
measures inadequate to prevent horizontal transmisson.16 On
the other hand, high infection rates may be associated with
patient complexity requiring more  invasive procedures and
longer ICU stay under high colonization pressure.
Yearly distribution of colonization/infection rates gives the
impression of a gradually increasing trend, especially at the
PICU. In 2013–2014, a substantial increase both in coloniza-
tion and infection was observed at the PICU. Because these
cases were not clustered in time, but dispersed throughout
the year, it was not considered as an outbreak. No change
has occurred in physical conditions and staff structure in that
year. It might have been a reﬂection of a considerably increas-
ing frequency of carbapenem resistance in Klebsiella isolates in
our country also, which has been shown recently in an adult
study.22
Literature review reveals primarily adult studies, which
deﬁned several risk factors for development of CRKP infection
in colonized patients.7,8,13–15,20 Serious underlying diseases
like diabetes mellitus, malignancies, or renal disease have
been previously reported risk factors for emergence of infec-
tions due to resistant microorganisms.9,13–16,20 In this study,
underlying neurological and metabolic diseases were more
frequently seen in CRKP-I group and the former was found
to be an independent risk factor for subsequentCRKP infec-
tion. Metabolic diseases, which are predominatly diseases of
the childhood, was ﬁrst reported to be an independent risk
factor for CRKP infection, which may be due to the scarcity
of pediatric studies on this issue. Neutropenia was deter-
mined as another risk factor for CRKP infection in colonized
patients. It is a rarely studied risk factor in similarly designed
studies.
In the current study, urinary catheterizaton, tracheostomy,
and previous surgical procedure were found to be more
frequently performed in patients with CRKP-I. On multivari-
ate analysis, previous surgical procedure was found as an
independent risk factor. Surgery is a well known risk fac-
tor for infection with resistant microrganisms like CRKP, as
shown in other published studies as well.15,21 Both coloniza-
tion and infection have been linked to the use of invasive
procedures.9,14,16,20 They facilitate the entry of the micror-
ganism to the host. However, for this entry to occur, the
microrganism should already exist in the natural or man-
made environment. So, because invasive procedures are not
avoidable in ICU patients most of the time, implementation
and good compliance of infection control measures to prevent
colonization of the environment and the patient are always
key points for reducing nosocomial infections with resistant
microorganisms.
Although it is generally accepted that there is a link
between antibiotic usage and emergence of resistant microor-
ganisms, literature review on this issue reveals conﬂicting
results. As there are studies reporting antibiotic exposure as
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n independent risk factor for CRKP infection,7,14,19,20,23 there
re also some other studies revealing no correlation between
ntimicrobials and isolation of CRKP.15,16,21,24 The current
ork found no difference in total duration of antibiotic usage
etween the CRKP-C and CRKP-I groups, because virtually
ll patients admitted to an ICU were heavily treated with
ntibiotics before CRKP detection. However, when individual
ntibotic groups were evaluated, carbapenem exposure was
ound to be a risk factor for subsequent CRKP-I. This ﬁnding
s in accordance with other studies that have reported strong
ssociation of exposure to carbapenem agents and CRKP
nfection.7,14,19,25 Carbapenem use may cause selective pres-
ure on persistence of the resistant microrganism, thereby
ncreasing infection risk. Although there are studies indi-
ating no effect of change in antimicrobial use in reducing
RKP infections,26 we  think thata the use of carbapenem
gents should be minimized, together with implementation
f appropriate and strict infection control programs to combat
mergence and spread of CRKP strains.
This study has several limitations. First, we could not deter-
ine types of carbapenameses harbored by CRKP strains,
ecause this was a retrospective study and molecular analy-
is were not routinely performed in our institution. Second,
eing a study with a retrospective design, it lacks enough
trength to establish a casual relationship between possible
isk factors for CRKP infection. Besides, there may be addi-
ional unmeasured variables associated with CRKP infection.
hird, we  could not implement a comorbidity index, which
ould measure the severity of comorbid conditions and min-
mize any selection bias, due to difﬁculties resulting from the
etrospective nature of the study design. Fourth, we did not
ave data about compliance of health care workers to infec-
ion control measures. It is obviously an impotant risk factor
or acquisiton of CRKP, but its role in infection occurrence in
atients who  are already colonized, which is the focus of our
tudy, remains to be answered in prospectively designed stud-
es. Data are limited regarding CRKP infection development
n critically ill pediatric and neonatal patients colonized with
RKP. Nonetheless, despite its limitations, this study provides
mportant information regarding infection control in this pop-
lation.
In conclusion, our data highlights the importance of CRKP
olonization, which resulted in infection in nearly half of the
atients admitted to the PICU and one ﬁfth of the patients in
he NICU. We  demonstrated several independent risk factors
or developing CRKP infection in patients initially colonized
ith CRKP, including underlying metabolic disease, neutrope-
ia, previous surgical procedure, and previous carbapenem
se. Patients with CRKP colonization especially those having
hese clinical factors should be targeted for interventions to
educe the risk of subsequent clinical infection. They should
lso be carefully followed up regarding signs and symptoms
f infection in order to timely initiation of empirical active
reatment against CRKP.onﬂicts  of  interest
he authors declare no conﬂicts of interest.
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